| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |